spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Repligen 

 HSMN NewsFeed - 28 Mar 2017
Akcea Therapeutics Announces Three Additions to Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 22 Jun 2015
Histogenics Corporation Announces Appointment of New Chief Financial Officer
Devices Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 4 Nov 2013
A.P. Pharma Makes Key Management Appointments
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Aug 2013
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2011
Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2010
Repligen Announces FDA and EMA Approval of Re-analysis of Images from Phase 3 Trial of RG1068 for Pancreatic Imaging
Biopharmaceuticals Radiology
 HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Aug 2009
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 10 Sep 2007
Repligen Announces Settlement with ImClone In Erbitux(R) Lawsuit
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 6 Sep 2007
Proteon Therapeutics Completes $12 Million Financing and Hires CFO
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Nov 2006
Repligen Receives Orphan Drug Designation from the FDA for RG1068 for MRI Imaging of the Pancreas
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2006
Repligen Reports Initiation of a Clinical Study of Secretin for Functional MRI Assessment of the Pancreas
Biopharmaceuticals Radiology
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
Repligen
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.